No­var­tis de­vel­op­ment chief John Tsai: 'We go deep in the new plat­form­s'

Dur­ing our re­cent Eu­ro­pean Bio­phar­ma Sum­mit, I talked with No­var­tis de­vel­op­ment chief John Tsai about his ex­pe­ri­ences over the 3-plus years he’s been at the phar­ma gi­ant. You can read the tran­script be­low or lis­ten to the ex­change in the link above.

John Car­roll: I fol­lowed your ca­reer for quite some time. You’ve had more than 20 years in big phar­ma R&D and you’ve ob­vi­ous­ly seen quite a lot. I re­al­ly was cu­ri­ous about what it was like for you three and a half years ago when you took over as R&D chief at No­var­tis. Ob­vi­ous­ly a big move, a lot of changes. You went to work for the for­mer R&D chief of No­var­tis, Vas Narasimhan, who had his own track record there. So what was the biggest ad­just­ment when you went in­to this po­si­tion?

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.